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TO THE EDITOR
Dengue is the most prevalent mosquito-
borne viral disease and is caused by
dengue virus (DENV), an enveloped
positive single-stranded RNA virus of
the family Flaviviridae. Aedes aegypti
and A. albopictus are the vectors of the
disease, and these mosquito species
have become widely distributed across
tropical and subtropical latitudes
(Bennett et al., 2010; Lambrechts
et al., 2010). Both vectors transmit the
disease by injecting DENV in the skin of
vertebrates together with saliva during
mosquito feeding. Various proteins
present in A. aegypti saliva will help
the mosquito successfully obtain a
blood meal by counteracting the
physiological responses by the vertebrate
host aimed to prevent blood loss and to
combat infection (review in Patramool
et al., 2012). However, the saliva also
contains numerous known, as well as
yet to be determined, proteins that are
essential for optimal transmission of
DENV and other arboviruses through
their capacity to modulate the host
immune response (Schneider et al.,
2010; Thangamani et al., 2010).
We have recently demonstrated that
A. aegypti saliva enhances DENV
replication in human keratinocytes
(Surasombatpattana et al., 2011) by
suppressing the secretion of anti-
microbial peptides (AMPs), S100A7,
Elafin, as well as IFNs in the earliest
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Figure 1. Aedes aegypti saliva proteins enhance dengue virus (DENV) replication in infected
keratinocytes. (a) Purified recombinant saliva proteins were run on 10% acrylamide gel and revealed by
silver staining. Lane MW: molecular-weight markers, lane 1: AT, lane 2: AD, lane 3: 34-kDa protein, lane
4: VA, and lane 5: HIV-1 gp120. (b) Keratinocytes were infected with DENV at a multiplicity of infection of
1 in the presence or absence of saliva proteins. At 24 hours after infection, intracellular viral RNA was
quantified by real-time reverse transcriptase–PCR. Results are expressed as viral RNA copies per microliter
in DENV-infected keratinocytes. Wilcoxon–Mann–Whitney test was used to determine the statistical
difference between sets of data. A value of Po0.05 was considered significant. *P-valueso0.05.
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stages of infection (Surasombatpattana
et al., 2012). Following a functional
genomic and proteomic analysis of
salivary glands of female A. aegypti
mosquitoes, we identified four additional
proteins that are abundantly present in
mosquito saliva (Wasinpiyamongkol
et al., 2010; Luplertlop et al., 2011)
and that were further characterized in
the present study for their capacity to
modulate DENV infection of human
keratinocytes. Each of these molecules,
Fxa-directed anticlotting serpin-like
protein (AT: GenBank accession number
Q1HRTV7_AEDAE), adenosine deaminase
(AD: Q179D4_AEDAE), a putative
34-kDa family secreted salivary protein
(34kD: Q1HRW0_AEDAE), and a putative
secreted protein (VA: Q8T9U5_AEDAE),
were produced as recombinant protein
in a baculovirus expression system and
purified by Ni-SepharoseTM 6 Fast
Flow resin (Figure 1a). Primary human
epidermal keratinocytes were inocu-
lated with DENV in the presence or
absence of each of the four proteins,
and intracellular viral mRNA levels
were quantified by real-time PCR
24 hours after infection. A significant
increase in the expression of DENV
transcripts was observed in keratino-
cytes infected with DENV in the pre-
sence of the proteins, as compared with
those in cells infected with DENV alone
(Figure 1b). This result is in agreement
with the notion that A. aegypti saliva
has an important role in creating an
environment suitable for DENV and
other arboviruses to replicate by inhibit-
ing host expression of antiviral immune
responses. It is noteworthy that for all
four proteins the increase in viral repli-
cation was more pronounced at
a concentration of 1mg ml1 than at
5mg ml 1, whereas at the former con-
centration the 34-kDa protein induced
the highest increase.
Type I IFNs are known to combat vir-
uses during viral infections, both directly
by inhibiting viral replication in the
cells and indirectly by stimulating innate
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Figure 2. mRNA expression of type 1 IFN, IFN-regulatory factors (IRFs), and antimicrobial peptides in DENV-infected keratinocytes. Cells were exposed to
dengue virus (DENV) at a multiplicity of infection of 1, in the presence or absence of saliva proteins at concentrations of 1 and 5mg ml1. mRNA expression of (a)
IFN-a, (b) IFN-b, (c) IRF3, (d) IRF7, (e) LL-37, (f) S100A7, and (g) RNase7 was analyzed by real-time quantitative reverse transcriptase–PCR at the indicated times.
Results are expressed as fold induction of transcripts in DENV-infected keratinocytes in the presence or absence of saliva proteins, relative to those in
mock-infected cells. Wilcoxon–Mann–Whitney test was used to determine the statistical difference between sets of data. A value of Po0.05 was considered
significant. *P-valueso0.05.
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and adaptive immune responses
(Gonza´lez-Navajas et al., 2012). In the
present study, AD and VA were found
to significantly inhibit the expression
of both IFN-a and IFN-b transcripts
already at 1 mg ml1, whereas the
effects at 5mg ml 1, in particular on
IFN-b mRNA expression, were less
pronounced (Figure 2a and b). Of all
four proteins, AT showed the weakest
effects. However, at both concentrations
the 34-kDa protein completely inhibited
type I IFN expression. The induction of
type I IFN responses is activated by two
transcription factors belonging to the
IFN-regulatory factor (IRF) family, IRF-3
and IRF-7, via the translocation of
dimerized IRF3 and IRF7 to the nucleus,
where they initiate IFN gene transcrip-
tion (Morrison et al., 2012). It has been
reported that the DENV protease
complex inhibits the phosphorylation
of IRF3, which results in a lack of
type I IFN production in human dendri-
tic cells (Gonza´lez-Navajas et al., 2012;
Morrison et al., 2012). To better
understand the molecular mechanism
that underlies the inhibition of type I IFN
by the salivary proteins, their effect on
the expression of IRF3 and IRF7 mRNA
was analyzed. In keeping with its effect
on type I IFN gene expression, the 34-kDa
protein also strongly suppressed the
expression of both IRF3 and IRF7
transcripts, at each of the concen-
trations used (Figure 2c and d). Although
the other three proteins had no signifi-
cant effect on IRF3 transcription, they
inhibited the expression of IRF7 mRNA
in DENV-infected keratinocytes. We
further investigated the expression levels
of AMPs that were previously found
to be inhibited by A. aegypti salivary
gland extracts (Surasombatpattana et al.,
2012). Using a wide range of concen-
trations, the 34-kD protein was found
to exert a dose–response-dependent
enhancement of DENV replication with
a maximal effect at the lowest doses
used (Supplementary Figure S1 online).
The data also show an inverse correla-
tion between the increase in viral repli-
cation and the decrease in expression of
each of the innate immune response
genes tested. A saliva-unrelated protein
did not affect DENV replication, thus
confirming the specificity of the 34-kDa
protein. The AT, AD, and VA proteins
also inhibited the transcription of
all three AMPs, although to a lesser
extent (Figure 2e–g). It is noteworthy
that keratinocyte-derived RNase7 has
broad-spectrum antimicrobial activity
against many pathogenic microorgan-
isms (Harder and Schroder, 2002). It
follows from our data analysis that the
strongly enhanced DENV replication by
the 34-kDa protein in human keratino-
cytes is associated with its strong
suppressive effects on the IRF signaling
pathway, resulting in the abrogation of
type I IFN production. Transcripts for the
34-kDa protein have previously been
identified in the salivary glands of adult
A. aegypti mosquitoes (Ribeiro et al.,
2007), and this protein was found to be
specific for the Aedes genus. Interes-
tingly, the 34-kDa protein has been
shown to be immunogenic in dengue-
infected patients (Wasinpiyamongkol
et al., 2010). In addition, the N-terminal
peptide of the 34-kDa protein repor-
tedly elicits IgG antibody responses in
children exposed to bites of A. aegypti
(Elanga et al., 2012). Although the func-
tion of the 34-kDa protein in mosquito
saliva was hitherto unknown, we show
in the present study that it may have a
major role in DENV infection in human
keratinocytes by suppressing antiviral
immune response in the earliest stages
of infection. The data presented here
provide the identification of a promi-
nently expressed protein in A. aegypti
saliva that could serve as a target for the
control of DENV replication in mam-
malian hosts.
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Mutation in AQP5, Encoding Aquaporin 5, Causes
Palmoplantar Keratoderma Bothnia Type
Journal of Investigative Dermatology (2014) 134, 284–287; doi:10.1038/jid.2013.302; published online 22 August 2013
TO THE EDITOR
Palmoplantar keratoderma (PPK) com-
prises a heterogeneous group of here-
ditary disorders characterized by
epidermal thickening of palms and
soles. According to the clinical appear-
ance, four subtypes of PPKs were classi-
fied, i.e., diffuse, focal, punctuate, and
striate PPK. Diffuse PPK can be further
subdivided into epidermolytic and non-
epidermolytic forms. One of the non-
epidermolytic PPKs is referred to as
PPK Bothnia type (PPKB, MIM600231),
which was initially described in two
Swedish families and was reported to
be prevalent in the north of Sweden,
along the Gulf of Bothnia (Lind et al.,
1994). The clinical characteristics of
PPKB include diffuse, homogeneous,
and even palmoplantar hyperkeratosis
with swollen stratum corneum, which
distinctively exhibits a whitish spongy
appearance upon exposure to water.
The inheritance pattern of PPKB is con-
sistent with the autosomal-dominant
mode, and the genetic locus has been
linked to a 14-cM interval on 12q11–
12q13 (Lind et al., 1994). We described
a Chinese family with PPKB, in which
we identified a gain-of-function muta-
tion in the aquaporin 5 gene, AQP5.
A large three-generation family of
Chinese Han ethnicity with PPKB was
ascertained, including 10 affected indi-
viduals (Figure 1a). The proband was a
28-year-old man presenting with slowly
progressive thickening of palms and
soles since the age of 3 years. Mild
palmoplantar hyperhidrosis was noted
especially in winter. He suffered with
recurrent tinea pedis and onychomyco-
sis caused by dermatophytes infection.
When examined, he was found to have
heterogeneous, even, yellowish hyper-
keratotic plaques on palms and soles,
and erythrokeratotic plaques with a
clear demarcation on the dorsum of
hands and feet (Figure 1b and c).
He also had skin maceration and
tinea unguium involving several nails.
After exposure to water for less than
1 minute, the stratum corneum swelled
and developed a whitish spongy appear-
ance (Figure 1d). Histopathological
findings of skin sample from the dorsum
of hand were nonspecific with ortho-
hyperkeratosis and mild inflammatory
infiltration of lymphocytes in the upper
dermis. All affected family members had
nearly identical features.
Peripheral blood samples were
collected from all family members
except the deceased, after written
informed consent in adherence to the
Declaration of Helsinki Principles and
approval by the institution review board
were obtained. We performed exome
sequencing in three individuals (III-8,
III-9, and III-14), including two affected
individuals and one normal individual.
Exomes were captured and enriched
using SeqCap EZ Human Exome Library
v3.0 (Roche NimbleGen, Madison, WI)
and were then sequenced on a Hiseq
2000 platform (Illumina, San Diego, CA)
according to the manufacturer’s instruc-
tions. Sequence variants were filtered
against public database (dbSNP137,
1000 Genomes Project, HapMap8) and
BGI in-house exome database. Under
the assumption of autosomal-dominant
pattern of inheritance with full pene-
trance, heterozygous variants present in
both the affected individuals but not in
the normal subject were selected as
possible candidates. Only two variants
involving AQP5 and SLC4A8 located
in previous linkage region of 12q11–
12q13 were detected (Supplementary
Table S1 online). Sanger sequencing con-
firmed these two variants in the two
affected individuals, but only the hetero-
zygous missense mutation in AQP5
(c.367A4T, p.Asn123Tyr; Figure 1e)
fully cosegregated with the PPKB phe-
notype in all the 23 family members.
This mutation was not detected in 300
ethnically matched unrelated subjects by
direct sequencing. The residue Asn123 is
evolutionarily conserved among most
species (Figure 1f). Interestingly, in a very
recently published abstract, Blaydon
et al. (2013) revealed mutations in
AQP5 leading to autosomal-dominant
diffuse non-epidermolytic PPK.
Aquaporins (AQP) are channel pro-
teins mostly responsible for rapid osmo-
tic water movement across the plasma
membrane in many cell types. AQP5 is
expressed in eccrine sweat glands and is
believed to be essential for secretion
(Nejsum et al., 2002; Ma et al., 2007)
despite controversy (Song et al., 2002).
In humans, hypohidrosis in Sjo¨gren’s
syndrome was associated with decrea-
sed expression of AQP5 (Iizuka et al.,
2012). Accordingly, we hypothesized
that mutation p.Asn123Tyr in AQP5
might lead to increased expression of
AQP5 in eccrine sweat glands and/or
exert a gain-of-function effect, thus cau-
sing hyperhidrosis in the affectedAccepted article preview online 18 July 2013; published online 22 August 2013
Abbreviations: AQP, aquaporin; HTS, hypotonic solution; PPK, palmoplantar keratoderma; PPKB,
palmoplantar keratoderma Bothnia type; TRPV4, transient receptor potential vanilloid 4; WT, wild type
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